The Dealmakers Forum E-Newsletter, October 30, 2013 – Another October without the Market Spooked, Balance Sheet Lending
Bringing You Senior Care M&A Deals and News October 30, 2013 Issue: Seniors Housing Weekly Update: 60 Seconds with Steve Monroe Another October without the Market Spooked. Unlike many Octobers past, stock market valuations are setting records, but only...Health Care Deal News, October 28, 2013 – The Largest Deal on the Technology Side of Health Care Wasn’t for a Drug, Our Third Quarter M&A Results are in—or out, The Largest Deal in the Health Care Services Sector Landed Squarely in the “Other” Category
Brought to you by www.DealSearchOnline.com October 28, 2013 Issue: Recent Health Care M&A Deals Hospitals Acquirer Target Price OSF Healthcare System Kewanee Hospital N/A Sabra Health Care REIT, Inc. Forest Park Medical Center $119.8 million...The Dealmakers Forum E-Newsletter, October 23, 2013 – Shutdowns, ObamaCare and Senior Care, LCB Senior Living Recently Closed on the Acquisition of an Alzheimer’s Facility Located in Rhode Island, Cap Rates
Bringing You Senior Care M&A Deals and News October 23, 2013 Issue: Seniors Housing Weekly Update: 60 Seconds with Steve Monroe Shutdowns, ObamaCare and Senior Care. The government shutdown and the chaotic opening of the health insurance exchanges provide a...PRESS RELEASE: Assisted Living Facilities: Buying, Selling and Valuing
FOR IMMEDIATE RELEASE David Grossman, Event Coordinator 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – October 30, 2013 – Irving Levin Associates, Inc. will be hosting an important webcast to address buying, selling and...Health Care Deal News, October 21, 2013 – Antibody-Drug Conjugates were all the Acquisition Rage Last Week, Fortis Healthcare is Selling Quality HealthCare Medical Services, MedImmune, Inc. was Busy This Week
Brought to you by www.DealSearchOnline.com October 21, 2013 Issue: Recent Health Care M&A Deals Biotechnology Acquirer Target Price Mesoblast Limited Stem Cell Therapeutic Business $50 million MedImmune, Inc. ADC Therapeutics $20 million MedImmune, Inc....Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
